Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Centrexion Therapeutics Logo
Centrexion Therapeutics Growth Score
53
CB Rank
31038
Heat Score
48
Centrexion Therapeutics is a late clinical-stage biopharmaceutical company addressing the treatment of chronic pain.
Founded
obfuscation
PrivateVenture - Series Unknown Boston, Massachusetts, United States11-50 centrexion.com
Biotechnology
Health Care
Pharmaceutical
Overview

Centrexion Therapeutics
Total Funding
obfuscation
Growth Score
53
Heat Score
48

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score53
-2 pts
in past quarter
Heat Score 48
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Centrexion Therapeutics

CB Rank
31038
Centrexion Therapeutics is a late clinical-stage biopharmaceutical company addressing the treatment of chronic pain.
Founded
obfuscation
PrivateVenture - Series Unknown Boston, Massachusetts, United States11-50 centrexion.com
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Centrexion Therapeutics Corp.
Operating Status Active
Company Type For Profit
Founders  Kerrie Brady, Sol Barer
About the Company
Centrexion Therapeutics is a late clinical-stage biopharmaceutical company focusing on identifying, developing, and commercializing non-opioid and non-addictive therapies to address the treatment of chronic pain.
Phone Number (410)522-8701
Contact Email info@centrexion.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CNTX-0290
An investigational small molecule SSTR4 agonist designed to treat chronic pain by targeting specific pain pathways.
CNTX-2022
A proprietary high concentration topical lidocaine gel formulated to address superficial musculoskeletal pain, dermatologic itch and pain, and superficial neuropathic pain.

Research & Development

Centrexion Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 12
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 12
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Centrexion Therapeutics Logo
Venture Round - Centrexion Therapeutics
2
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 7 Board Members and Advisors 3 Contacts 17

Employee Profiles

Board Members and Advisors

News

News and Press

News•Oct 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 25, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 24, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 17, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

181
-11.71%
 in past month

IT Spend

$83KThis year, Centrexion Therapeutics is projected to spend $83K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Data Theft Logo
Data Theft
82
High-Value Customer Logo
High-Value Customer
80
Real Time Personalization Logo
Real Time Personalization
68

Actively Used Products

18Centrexion Therapeutics uses 18 technology products and services including HTML5, DigiCert, and  Google Analytics, according to G2 Stack.

Active Website Tech Count

5Centrexion Therapeutics is actively using 5 technologies for its website, according to BuiltWith. These include DNSSEC, IPv6, and  CommonCrawl Top 10m.

Total IP

54The intellectual property of Centrexion Therapeutics includes 50 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Centrexion Therapeutics has registered 4 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Centrexion Therapeutics's headquarters? Centrexion Therapeutics is located in Boston, Massachusetts, United States.Who invested in Centrexion Therapeutics? Centrexion Therapeutics has 9 investors including SLR Capital Partners and  Exome Asset Management.When was the last funding round for Centrexion Therapeutics? Centrexion Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Centrexion Therapeutics's competitors? Alternatives and possible competitors to Centrexion Therapeutics may include Alto Neuroscience, Aspen Global Incorporated, and  MilanaPharm.How much funding has Centrexion Therapeutics raised to date? Centrexion Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|